RedCo II Master Fund, L.P. Acquires Pre-Funded Warrants in ADC Therapeutics SA

RedCo II Master Fund, L.P. acquired Pre-Funded Warrants to purchase Common Shares of ADC Therapeutics SA in a private placement on October 27, 2025. The purchase price per Pre-Funded Warrant was $3.90, which is the price per Common Share in the private placement minus the exercise price per Pre-Funded Warrant. The Pre-Funded Warrants are exercisable at any time on or after the closing date until the tenth anniversary of the closing date, subject to a 9.99% beneficial ownership blocker. Redmile Group, LLC, the investment manager of RedCo II, and Jeremy Green, the principal of Redmile, may be deemed to beneficially own the reported securities. Both Redmile and Mr. Green disclaim beneficial ownership except to the extent of their respective pecuniary interests.